BillionToOne (BLLN) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
22 Apr, 2026Executive summary
The 2026 Annual Meeting will be held virtually on June 10, 2026, with voting available online, by phone, or by mail.
Stockholders will vote on electing two Class I directors and ratifying the appointment of PricewaterhouseCoopers LLP as the independent auditor for 2026.
The company has a dual-class share structure, with Class B shares carrying 15 votes per share and Class A shares carrying one vote per share.
Proxy materials and the 2025 Annual Report are available online, with an emphasis on reducing environmental impact through electronic delivery.
Voting matters and shareholder proposals
Two directors, Oguzhan Atay and Akshay Rai, are nominated for election as Class I directors for a three-year term expiring in 2029.
Stockholders are asked to ratify PricewaterhouseCoopers LLP as the independent auditor for 2026.
The board recommends voting FOR both proposals.
Procedures for submitting shareholder proposals and director nominations for the 2027 meeting are detailed, with deadlines and requirements specified.
Board of directors and corporate governance
The board consists of seven members divided into three staggered classes, with a mix of executive and independent directors.
The board is chaired by the CEO, with a lead independent director appointed.
Audit and Compensation Committees are fully independent and comply with Nasdaq and SEC requirements.
The board held nine meetings in 2025, with all directors attending at least 75% of meetings.
Latest events from BillionToOne
- Election of directors and auditor ratification headline the June 2026 virtual annual meeting.BLLN
Proxy filing21 Apr 2026 - 2025 revenue doubled, margins rose, profitability achieved, and 2026 guidance raised to $430–$445M.BLLN
Q4 20255 Mar 2026 - Single-molecule NGS innovation drives rapid growth, high margins, and expanding market share.BLLN
44th Annual J.P. Morgan Healthcare Conference12 Jan 2026 - Q3 2025 revenue up 117% YoY, 70% gross margin, and GAAP profitability achieved.BLLN
Q3 202510 Dec 2025 - Rapidly growing diagnostics firm with advanced technology, strong margins, and large market potential.BLLN
Registration Filing29 Nov 2025 - IPO offers 3.85M shares at $49–$55, funding growth in $100B+ precision diagnostics.BLLN
Registration Filing17 Oct 2025